Postmarket Surveillance Studies with David Rutledge

In this episode, we’re going to talk about Postmarket Surveillance Studies. 

In light of the EU Medical Device Regulation (MDR), medical device manufacturers are required to implement a Postmarket Surveillance (PMS) plan, which in turn may require them to conduct Postmarket Surveillance Studies. 

To learn about Postmarket Surveillance Studies regulatory requirements, process for collecting clinical data for such studies, key elements of PMS plan, and more, I invited Dr. David Rutledge on the podcast.

David is the President & CEO at Global Strategic Solutions, where he works as a global consultant for clinical evaluations, clinical risk management, regulatory, quality, and clinical investigations. 

David brings over 25 years of experience and knowledge in product-level analysis, clinical protocol and case report form development, scientific data analysis, organizational design, integration of science with business needs, quality management systems, signal detection, global clinical evaluations, clinical risk management, and regulatory affairs. 

David is Six Sigma and CAPA certified, an ISO 13485 lead auditor, the author of Mythical Medical™: Revelations from a Global Product Approval Consultant. 


Leave a Reply

Your email address will not be published. Required fields are marked *

Share On Facebook
Share On Twitter
Share On Linkedin
Share On Pinterest
Contact us